No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

U.S. News & World Report Names Tampa General Hospital as Best in Tampa Bay

Editor: What To Know

  • Tampa General is also listed among the top four hospitals in Florida and ranked as one of the nation’s top 50 hospitals in five medical specialties, according to the digital media company.
  • Tampa General is ranked as one of the nation’s 50 top hospitals, as well as the top hospital in Florida, in these five medical specialties.
  • The annual Best Hospitals rankings and ratings, now in their 32nd year, are designed to help patients and their doctors in making informed decisions about where to receive care for challenging health conditions or for common elective procedures.

Tampa General Hospital is once again ranked as the #1 hospital in Tampa Bay by U.S. News & World Report for 2021-2022.

This is the sixth consecutive year that Tampa General has been named by U.S. News & World Report as Tampa Bay’s top hospital. Tampa General is also listed among the top four hospitals in Florida and ranked as one of the nation’s top 50 hospitals in five medical specialties, according to the digital media company.

The annual Best Hospitals rankings and ratings, now in their 32nd year, are designed to help patients and their doctors in making informed decisions about where to receive care for challenging health conditions or for common elective procedures. The high U.S. News rankings are a sign of Tampa General’s ability to treat the most complex illnesses and conditions, said TGH President and CEO John Couris.

“Year after year, Tampa General has been recognized as a leading healthcare system by U.S. News & World Report, considered by healthcare consumers as the global leader in quality rankings. Consistency in performance is what is most important as we continue on our journey to become the safest and most innovative academic health system in America,” Couris said. “I’m incredibly proud of our physicians and team members who deliver world-class care to our patients every day. Their dedication and commitment is the reason that Tampa General ranks so highly.”

Tampa General, the primary teaching hospital of the USF Health Morsani College of Medicine and one of the nation’s largest hospitals, is the leading academic medical center on the West Coast of Florida. It is known for performing the most challenging procedures and treating the most complex illnesses.

Tampa General is ranked as one of the nation’s 50 top hospitals, as well as the top hospital in Florida, in these five medical specialties:

  • Ear, Nose & Throat – ranked #21 in U.S. and #1 in Florida
  • Orthopedics – ranked #23 in U.S. and #1 in Florida
  • Gastroenterology & GI Surgery – ranked #26 in U.S. and tied for #1 in Florida
  • Diabetes & Endocrinology – ranked #28 in U.S. and #1 in Florida
  • Rehabilitation – ranked #36 in U.S. and tied for #1 in Florida

Tampa General also ranks as “high performing,” or among the top 10% of U.S. hospitals, in four more specialties:

  • Cancer
  • Geriatrics
  •  Neurology & Neurosurgery
  • Pulmonology & Lung Surgery

Finally, Tampa General also ranks as “high performing” in 12 procedures and conditions that include: Abdominal Aortic Aneurysm Repair, Acute Kidney Failure, COPD, Diabetes, Heart Attack, Heart Bypass Surgery, Heart Failure, Hip Replacement, Knee Replacement, Pneumonia, Spinal Fusion and Stroke.

For the 2021-22 rankings and ratings, U.S. News evaluated more than 4,750 medical centers nationwide in 15 specialties and 17 procedures and conditions. In the 15 specialty areas, 175 hospitals were ranked in at least one specialty. In rankings by state and metro area, U.S. News recognized hospitals as “high performing” across multiple areas of care.

“This year’s expanded report from U.S. News includes new ratings for important procedures and conditions to help each patient pick the right hospital for the type of care they need,” said Ben Harder, managing editor and chief of health analysis at U.S. News. “Hospitals faced incredible challenges this past year, and the best of them have provided great care throughout the pandemic and continue to offer excellent care today.”

The U.S. News Best Hospitals methodologies in most areas of care are based largely on objective measures such as risk-adjusted survival and discharge-to-home rates, volume, and quality of nursing, among other care-related indicators. Best Hospitals was produced by U.S. News with RTI International, a leading research organization based in Research Triangle Park, N.C.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."

Sedana Medical Completes Patient Recruitment for INSPiRE-ICU 1 Clinical Trial in the US

Peter Sackey further elaborated: "Once the 30-day follow-up of all patients is complete, we will enter into an intense phase of final monitoring, data cleaning and transfer to our statistician team for analysis. In parallel, the long-term outcomes at 3 and 6 months will be collected centrally by the Critical Illness, Brain Dysfunction, and Survivorship team at Vanderbilt Medical Center. With this parallel approach, we expect topline results in the autumn of this year and a swift regulatory submission in Q1, 2025".

Health / Lifestyle

Articles of Interest

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy